Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cardiol Therapeutics Inc. CRDL

Primary Symbol: T.CRDL Alternate Symbol(s):  T.CRDL.W.A

Cardiol Therapeutics’ lead product, CardiolRx™, is an oral pharmaceutical that is currently being evaluated in the Phase II multi-national ARCHER trial in patients presenting with acute myocarditis. Cardiol has received IND authorization from the FDA to conduct a clinical study to evaluate CardiolRx™ in a Phase II multi-center open-label pilot study in recurrent pericarditis. Cardiol is developing a subcutaneously administered drug formulation of cannabidiol intended for use in heart failure.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:Picked up a few more shares

Its on the run im picking up shares  rate and reply

Picked up a few more shares

Can't resist. Anything below two dollars I think as a gift to us. Just waiting to hear about phase 2. The markets have been rocked but the potential here outweighs much of the noise. more

Fokus Mining: Best Drill Results to Date

"We are very pleased with these results, which suggest that the RB zone may extend to the surface. Although further drilling is required to confirm this hypothesis, this possibility is very promising. This would be even more interesting as it would open up other prospects for the GP Zone adjacent to the RB Zone," said Jean Rainville, President and CEO. more

Today in the Financial News…

Nice run today....this was published today in the Financial News...maybe part of the reason. I've sold off most of what I owned in the $4-5 profit range as I've been disappointed more

RE:Cardiol will run north in time no doubt

OMG   back to pumping   rate and reply

Cardiol will run north in time no doubt

Cardiol Therapeutics shares could go up in value very quickly here! With the world under a Covid umbrella that doesn't appear to folded up by mother nature anytime soon, Cardiol is in a more

Knock Knock

Guess nobodys here lol Disregard post below, wrong board.  rate and reply

RE:Could have made

Get it right dirty ole slimer I paid $2.30 and as i said i will be back when sp goes to $3 and more. My H has a lot invested in this and he has a great software program which has helped us both more

Cardiol Therapeutics Announces Year-End 2021 Update

Expanded the Phase II/III LANCER clinical trial in patients with cardiovascular disease (CVD), or significant CVD risk factors, who are hospitalized with COVID-19 more


Eom  rate and reply

Is Eden still high on the cardiol?

Tia  rate and reply

Thank you :)

I liked your PM and am flattered but sorry I do not PM. So I won't name you but just wanna say on here thank you for the compliments. Bubula  rate and reply


Good Morning Bullknit Sounds like you are very unhappy :( Don't be depressed. As a bull instead of looking at the green grass, all you see is that red . The market is a bloodbath more

RE:Shelf prospectus on sedar

Nice - this should really do in the Shareholders.  rate and reply


Correction - was a $50M public offering. Still, this devastated the share price. And, you have to wonder which CBD vailble everywhere and available as an API via Jazz Pharma, I fail to see what more


There a no posts because there is nothing here to see. I'm tired of seeing pumping and people losing lots of money, it's depressing. This company was pumped this summer and then when more

RE:Receives Clearance from the FDA and Regulatory Agencies

Note: This is the Full Title Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite more

Receives Clearance from the FDA and Regulatory Agencies

LANCER Trial expanded to include up to 20 Additional Clinical Research Centers Oakville, Ontario--(Newsfile Corp. - March 1, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" more


Stock up 8% And no one posts. We all know it's gonna fly. No Brainer. What kind of board is this ? Like 3 posts a month. Hahahaha  rate and reply

Shelf prospectus on sedar

$150 million USD good for 25 months  rate and reply

RE:RE:I can see this board being very interesting

Hey New fan CBD looks like just you and me here on this board Geeez altho over 80 reads on my post so there is some interest. I just finished a 10 hourshift, i saw on your profile you work in more